BCHE and Alzheimer disease: Currently, the most prescribed drug class for AD treatment is cholinesterase (ChE) inhibitors, e.g., rivastigmine, donepezil, and galanthamine, whereas memantine as another drug option acts through N-methyl-D-aspartate (NMDA) receptor antagonism [7,8,9].